News
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
February 7, 2019
Results from a large RCT showed intensive and standard insulin regimens produced similar clinical outcomes after an acute ischemic stroke.
News
Pulmonary hypertension linked to complications after head and neck procedures
February 1, 2019
SAN DIEGO – The odds of in-hospital mortality were not significantly different for those with PHTN.
News
Aspirin for primary cardiovascular prevention, RIP
January 30, 2019
SNOWMASS, COLO. – “Is aspirin safe and effective for primary prevention? The short answer here is no.” –Dr. Patrick T. O’Gara
News
Subclinical hypothyroidism boosts immediate risk of heart failure
January 24, 2019
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.
News
Obesity paradox applies to post-stroke mortality
January 17, 2019
CHICAGO – Overweight and obese VA stroke patients have lower 30-day and 1-year all-cause mortality after an in-hospital stroke.
News
SGLT-2 inhibitors promising for heart failure prevention, not treatment
January 12, 2019
LOS ANGELES – The combination of heart failure and diabetes is particularly lethal.
News
RE-SPECT ESUS: Dabigatran matched aspirin for second stroke prevention
January 9, 2019
MONTREAL – In an international trial with 5,390 patients, dabigatran proved no better than aspirin for second stroke prevention following ESUS.
News
New diabetes drugs solidify their cardiovascular and renal benefits
January 7, 2019
CHICAGO – Empagliflozin’s heart failure and renal benefits surprised when reported in 2015. The evidence has grown stronger and broader since.
News
Can higher MAP post cardiac arrest improve neurologic outcomes?
December 21, 2018
CHICAGO – A target mean arterial pressure higher than what the guidelines recommend appears safe but has mixed results for improving neurologic outcomes.
News
Digital alerts reduced AF-related stroke, MI rates
December 18, 2018
CHICAGO – A computerized decision support system increased anticoagulation rates and reduced cardiac event rates in at-risk atrial fibrillation patients.